Patent Oppositions in peptide synthesis industry

Explore the competitive field of peptide synthesis where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in peptide synthesis technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the peptide synthesis industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the peptide synthesis industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Oct 1, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Compositions And Methods Of Treating Lupus NephritisF HOFFMANN LA ROCHESep 30, 2026MAIWALD PATENTANWALTS
Compositions And Methods Of Treating Lupus NephritisF HOFFMANN LA ROCHESep 30, 2026KERNEBECK PATENTANWALTS
Cytotoxicity-Inducing Therapeutic AgentCHUGAI SEIYAKU KABUSHIKI KAISHASep 29, 2026STRAWMAN
Compositions And Methods Of Treating Lupus NephritisF HOFFMANN LA ROCHESep 29, 2026WUESTHOFF & WUESTHOFF
Compositions And Methods Of Treating Lupus NephritisF HOFFMANN LA ROCHESep 29, 2026WUESTHOFF & WUESTHOFF
Lipid Nanoparticle Compositions And Methods For Mrna DeliveryTRANSLATE BIOSep 24, 2026GLAXOSMITHKLINE BIOLOGICALS SA
Lipid Nanoparticle Compositions And Methods For Mrna DeliveryTRANSLATE BIOSep 23, 2026PFIZER
Binding Molecules For Bcma And Cd3AMGENSep 18, 2026ABBVIE
Methods Of Treating Crohn'S Disease With Anti-Il23 Specific AntibodyJANSSEN BIOTECHSep 14, 2026SIMMONS & SIMMONS
Formulation For Anti-Alpha4Beta7 AntibodyMILLENNIUM PHARMACEUTICALSSep 10, 2026CAMULON

To stay ahead in the competitive peptide synthesis industry, companies are constantly innovating. Here are the top patents facing oppositions in the peptide synthesis industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Oct 1, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Mar 11, 2015Treatment Of Tnf Alpha Related DisordersABBVIE BIOTECHNOLOGY13
Jan 10, 2018Method To Improve Virus Removal In Protein PurificationF HOFFMANN LA ROCHE11
Jan 18, 2017Methods Of Administering Anti-Tnfalpha AntibodiesABBVIE BIOTECHNOLOGY11
Nov 1, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH11
Nov 2, 2016Multiple-Variable Dose Regimen For Treating Tnfalpha-Related DisordersABBOTT BIOTECHNOLOGY11
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA THERAPEUTICS, INC.10
Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS10
May 15, 2019Combination Therapy For The Treatment Of Ovarian CancerF HOFFMANN LA ROCHE10
Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLUDWIG MAXIMILIANS UNIVERSITT MNCHEN10
Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentOSAKA UNIVERSITY10